Needlefree Connection Systems and Associated Products

A small, stand-alone, Luer-activated needleless plastic valve intended to mate two related intravenous (IV) line devices [e.g., hypodermic syringe and catheter port or tubing from an IV administration set] and hold them in a secured, sealed, locked position until disconnection. It is a device that allow connection of a syringe to a vascular access device whilst eliminating the use of needles when administering fluids or medication to a patient. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £7,500,000 in the first year for Lot 1 of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

A collection of tubing/s with integrated needle-free connector and valve, intended to establish an extension to allow repeated access to the intravenous system eliminating the use of needles. For example these may be made from either Polyethylene, Polyethylene lined PVC, PVC, or Polyurethane. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £18,750,000 in the first year for Lot 2 of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

Disinfection Caps (Luer-formatted disinfection caps) A small, non-invasive, closed-ended Luer attachment intended to be attached to a connector in an intravenous line (e.g., needleless valve, Luer access valve, male Luer connector) to disinfect the valve surface and/or maintain disinfection, and for protection. For Example, a synthetic polymer cap containing a foam material saturated with isopropyl alcohol (IPA) as the disinfectant; it may contain other components. Closed System transfer devices (CSTD) - These are medication transfer sterile devices designed to transfer parenteral medications(e.g., intravenous (IV) fluids, drugs] between a first container(s) [e.g., a vial(s) and a second container or administration line (e.g., an IV bag/line) in a non-powered closed system; it may also be used to compound and/or reconstitute medication for its preparation and administration. It is available in a variety of configurations and typically includes vials, tubes, connectors, spikes, syringes, and caps. This is a single-use device. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £2,500,000 in the first year for Lot 1 of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.